SCHEMBL7068841

SCHEMBL7068841

COC1=CCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10904062 0.82
SCHEMBL1683755 0.76
SCHEMBL22208391 0.74
SCHEMBL31406724 0.72
SCHEMBL18137507 0.72
SCHEMBL15062282 0.67
SCHEMBL7634919 0.67
SCHEMBL18930034 0.66
SCHEMBL3199056 0.66 PREP (0.31)
SCHEMBL15020363 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160367693-A1 Selective Arylation of Dichalcogenides in Biomolecules NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-22 US disclosed
US-8980938-B2 CXCR2 inhibitors SANOFI (FR) 2015-03-17 US disclosed
EP-2416777-B1 THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES SANOFI SA (FR) 2014-11-12 EP disclosed
US-8642643-B2 CXCR2 antagonists SANOFI (FR) 2014-02-04 US disclosed
US-20090258936-A1 CXCR2 INHIBITORS SANOFI-AVENTIS (FR) 2009-10-15 US disclosed
US-20090258906-A1 CXCR2 ANTAGONISTS SANOFI-AVENTIS (FR) 2009-10-15 US disclosed
US-6518299-B1 Trans-5-(1-Acetylamino-2-ethyl)butyl-1 -aminoiminomethylpyrrolidine-3-carboxylic acid BIOCRYST PHARMACEUTICALS, INC. 2003-02-11 US disclosed